In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans

Antimicrob Agents Chemother. 2002 Oct;46(10):3323-6. doi: 10.1128/AAC.46.10.3323-3326.2002.

Abstract

To develop new approaches for the treatment of invasive infections caused by Scedosporium prolificans, the in vitro interaction between amphotericin B and pentamidine against 30 clinical isolates was evaluated using a checkerboard microdilution method based on the National Committee for Clinical Laboratory Standards M38-P guidelines. The interaction between the drugs was analyzed using fractional inhibitory concentration index (FICI) analysis and response surface modeling. Amphotericin B alone was inactive against all the isolates. The geometric mean MIC for pentamidine was 57 micro g/ml (range, 8 to 256 micro g/ml; MIC at which 50% of the isolates tested were inhibited [MIC(50)], 64 micro g/ml; MIC(90), 128 micro g/ml). The combination was synergistic against 28 of 30 isolates (93.3%) by FICI analysis and 30 of 30 (100%) by response surface modeling analysis. Antagonism was not observed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology*
  • Antifungal Agents / pharmacology*
  • Drug Synergism
  • Humans
  • Microbial Sensitivity Tests / methods
  • Models, Biological
  • Pentamidine / pharmacology*
  • Scedosporium / drug effects*

Substances

  • Antifungal Agents
  • Pentamidine
  • Amphotericin B